Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Clinical Trials Market
Clinical Trials Market Share
- Report ID: GMI5029
- Published Date: Apr 2023
- Report Format: PDF
Clinical Trials Market Share
- Thermo Fisher Scientific (PPD, Inc)
- Clinipace Inc
- ICON plc
- Charles River Laboratories (MPI Research)
- IQVIA
- Medpace,Laboratory Corporation of America Holding (Covance Inc)
- The Emmes Company LLC
- Parexel International Corporation
- Syneos health
- WuXi AppTec
are some of the well-known clinical trial companies worldwide. Apart from focusing on innovative ventures, these industry players are actively adopting several collaboration initiatives to expand their global presence.
Frequently Asked Questions (FAQ) :
Global market for clinical trials recorded more than USD 55.5 billion in 2022 and is anticipated to exhibit 5.9% CAGR from 2023-2032 due to the significantly increasing number of initiatives undertaken by several government and non-government organizations.
Phase III segment may exceed USD 45.5 billion by the end of 2032 with increasing usage for demonstrating the improvements and equality to the standard of care of the new combination of drugs.
North America held over 54% of the clinical trials market share in 2022 driven by the rapidly growing geriatric population in the region suffering from several chronic diseases and age-related disorders.
Thermo Fisher Scientific (PPD, Inc), Clinipace Inc, ICON plc, Charles River Laboratories (MPI Research), IQVIA, Medpace, The Emmes Company, LLC, Parexel International Corporation, Syneos health, and WuXi AppTec are some prominent market participants.
Clinical Trials Market Scope
×
Get a free sample of
Clinical Trials Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below